文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > 2011 替吉奥同步放疗治疗局部晚期和复发性胰腺癌的Ⅱ期临床试验
侵权投诉

2011 替吉奥同步放疗治疗局部晚期和复发性胰腺癌的Ⅱ期临床试验

上海医学2011年第34卷第5期

367

●

论著

●

替吉奥同步放疗治疗局部晚期和复发性胰腺癌

的Ⅱ期临床试验

吴莉莉

楼文晖

曾昭冲

曾蒙苏

李婷婷

姬

巍

【摘要】目的探讨低剂量替吉奥同步放疗治疗局部晚期和复发性胰腺癌的疗效和安全性。方法收集

16例经病理检查证实或符合临床诊断标准的局部晚期胰腺癌患者或术后复发患者,应用15MV直线加速器,肿瘤大体靶区(GTV)为肿瘤组织和转移淋巴结,临床靶区(CTV)=GTV,淋巴引流区不行预防性照射。计划靶区(PTV)一GTV+1.0cm,95%PTV接受总放疗剂量50.4Gy 28次1 5.5周_1(单次剂量为1.8Gy)外放疗。同时予替吉奥40rag/次,每天1次,治疗前2.5~3.5h(中位数为3h)口服,1周5d。放疗结束4周后复查CT测量病灶体积改变,检测肿瘤标志物水平,用实体瘤疗效反应的评价标准(responseevaluationcriteria

insolid

tumors,RECIST)评价治疗效果,根据国立癌症研究所的常规毒性判定标准(NCICTCAE3.O)评价毒

副反应。结果共入组16例患者,均完成放化疗。治疗有效率为3/16,肿瘤控制率为12/16。最常见的毒副反应为恶心(13/16)。无3度及以上骨髓抑制。所有毒副反应均属能够耐受范围。结论

对局部晚期和复发胰腺

癌,低剂量替吉奥同步放疗增敏是一种安全的同步选择。其毒副反应少,局控效果较好,但远期效果还有待观察。

【关键词】胰腺癌;同步放化疗;替吉奥;局部晚期

PhaseⅡtrialoflowdosageS-1

recurrent

concurrent

withradiotherapyinpatients

with

locallyadvanced

Tingting,JI

or

pancreatic

cancer

。WULili,LOUWenhui,ZENGZhaochong,ZENGMengsu,LI

Wei.

。Deportment

ofRadiation

Oncology,ZhongshanHospifal,FudenUniversity,Shanghai200032,China

Correspondingauthor:LOU

Wenhuf.E-mail:lou.wenhui@zs-hospita『.sh.cn;ZENGZhoochong,E-mail:

zeng.zhaochong@ZS—hospifal.sh.cn

[Abstract]Objective

fortreatmentof

patients

ToevaluatetheefficacyandsafetyoflowdosageS-1

concurrent

withradiotherapy

criteria

were

with

or

locally

advanced

orrecurrentlocally

pancreatic

cancer.Methods

or

Eligibility

pathologicallyconfirmedadministeredGywas

orallyat

fl

clinically

diagnosed

once

advancedrecurrent

pancreatic

cancer.孓1

totaldoseof

was50.4

doseof

40mg

daily

3hbefore

radiotherapy(5

using

a

daysperlinear

week).A

appliedbydailyfractionsofconfinedto

nodal

the

1.8Gy,5days

primary

perweek15MV

accelerator.Thegrosstumor

target

volume(GTV)wasGTV,no

tumorand

metastaticlymphnodes.Clinical

was

volume(CTV)2

withinthe

isodose

prophylactic

irradiated,PTV=CTV+1.0cm,and95%PTV

NClCTCAE3.0(response

CT

encompassed

criteria

in

Iine.Toxicitiesresponse16

was

wereevaluatedusingthe

evaluation

solidtumors).Tumor

Atotal

of

assessedusing

multidetector

according

toRECIST4weeksaftertreatment.Results

responserateduringall

patients

and

were

included

forevaluationofefficacyand

mostabove

toxicity.The

reaction

anddiseasecontrolratewere

3/1612/16,respectively.The

was

no

commontoxicconcurrent

radiotherapy

tolerable

wasnausea

(13/16).There

Conclusions

grade3

S-1

or

myelosuppression,and

shows

toxicitieswereandtransient.

Lowdose

concurrentwithradiotherapy

itiswelI

favorable

efficacyagainstlocally

advanced

or

recurrencepancreatic

cancer,andtolerated,buttheIong-termresultsstilIneedto

be

furtherobserved.

(ShanghaiMedJ,2011,34:367—370)

[Keywords]Pancreaticcancer;Concurrentchemoradiotherapy;S一1;Localadvanced作者单位:200032上海,复旦大学附属中山医院放疗科(吴莉莉、曾昭冲、李婷婷、姬巍),普外科(楼文晖),影像科(曾蒙苏)

通信作者:楼文晖,电子邮箱为lou.wenhui@zs-hospital.sh.C11;曾昭冲,电子邮箱为zeng.zhaochong(勇zs-hospital.sh.cn

胰腺癌的发病率逐年升高,病死率高达95%,5年生存率在5%以下。初次诊断为胰腺癌的患

者中,局部晚期者约占40孵11,即使成功行手术切

万方数据

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email